Importance of the Early Detection of FRAAs
Early detection of folate receptor autoantibodies (FRAAs) can prevent neurodevelopmental disorders like ASD and CFD. Learn why early testing matters.
The early detection of folate receptor autoantibodies is necessary because it can lead to timely diagnosis and appropriate management of conditions associated with these autoantibodies. Folate receptor autoantibodies have been found in Cerebral Folate Deficiency Syndrome, Autism Spectrum Disorders, Schizophrenia, Depression and Neural Tube Defects, among other neurodevelopmental disorders.
The timely initiation of appropriate treatment, such as alternate reduced folates and/or dietary adjustments, may lead to optimal outcomes and improved overall prognosis for the individual.
As with any medical test, the interpretation of the results and the subsequent treatment plan should be discussed with a qualified healthcare professional.
We continuously research the significance of folate receptor autoantibodies and their implications in various neurodevelopment and neuropsychiatric disorders.
Early detection of folate receptor autoantibodies (FRAAs) can prevent neurodevelopmental disorders like ASD and CFD. Learn why early testing matters.
ATP is the engine of life—understand its discovery, structure, and function in powering cells through respiration, fermentation, and photosynthesis.
Discover how FRAAs, the FRAT® test, and folinic acid offer targeted hope for ASD, PANS/PANDAS, and more through folate transport correction.
Discover the FRAT® test—an advanced diagnostic for folate receptor autoantibodies linked to autism, NTDs, and neurodevelopmental disorders.
Discover why the FRAT® test is crucial for detecting folate receptor autoantibodies linked to autism, CFD, and neurological symptoms.
Explore the hidden engine of life—cellular respiration. Discover how glucose, oxygen, and the mitochondrial respiratory chain power every cell through a fascinating journey of energy transformation.
Learn how folate receptor autoantibodies (FRAAs) block folate transport at the BBB, causing cerebral folate deficiency despite normal blood folate levels.
Discover how maternal autoantibodies may impact fetal brain development and increase autism risk. Learn more about MAR-ASD, key proteins, and emerging research.